期刊文献+

β-内酰胺酶同步检测方法的建立与临床应用 被引量:2

Establishment of β-lactamase synchronous detection method and its clinical application
下载PDF
导出
摘要 目的建立同步检测超广谱β-内酰胺酶(ESBLs)和AmpC β-内酰胺酶(AmpCs)的头孢噻肟平板试验(CTX-AM),并研究β-内酰胺酶在肠杆菌科细菌中的流行情况及对其耐药性的影响。方法应用琼脂稀释法和CTX-AM分别测定分离菌的最低抑菌浓度(MIC)和产酶情况,并对产与不产酶菌株的耐药性进行比较。以肺炎克雷伯菌ATCC 700603、阴沟肠杆菌029M和大肠埃希菌ATCC 25922作质控,并与双纸片增效试验(DDET)和酶粗提物三维试验(TDEM)进行比对。结果CTX-AM检出的产AmpCs菌株与TDEM检测结果完全一致,同时产ESBLs和AmpCs的11株菌中,DDET检出8株ESBLS阴性;且CTX-AM识别的产耐酶抑制剂β-内酰胺酶和产其他广谱酶的菌株,DDET未能识别。183株菌中,33.9%、3.3%、6.6%和14.8%分别单产ESBI。S、AmpCs,同时产ESBLs/AmpCs和其他广谱酶。亚胺培南抑菌活性最高(MIC90=0.5mg/L),72%以上单产ESBLS菌株对哌拉西林/他唑巴坦、头孢西丁、头孢吡肟和头孢哌酮/舒巴坦敏感,66%以上单产AmpCs菌株对头孢吡肟敏感,而同时产生ESBLs/AmpCs菌株对除亚胺培南外的抗生素敏感性均低于20%。结论CTXAM操作简便,易于判读,成本低廉,在一块平板上即可完成对ESBLs和AmpCs的检测。 Objective To establish an easy, rapid and reproducible cefotaxime-agar medium (CTX-AM) for phenotypic detection of extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases (AmpCs) synchronously, and to investigate the prevalence of ESBLs in Enterobacteriaceae and its impact on antibiotic susceptibility. Methods 183 clinical Enterobacteriaceae isolates were enrolled in the study. The minimal inhibitory concentration (MIC) was determined by standard agar dilution method, and the statue of β-1actamase production by cefotaxime-agar medium(CTX-AM) method. The resistance of β-1actamase producting strains and nowproducting strains was compared. A total 183 isolates of Enterobacteriaceae,as identified by the double-disk enhancement test (DDET) and the threedimensional extract method(TDEM), were used to evaluate the CTX-AM method. K. pneumoniae ATCC700603,E. cloacae 029M and E. coli ATCC25922 were set as quality controls. Results The de tected AmpCs-producing strains by CTX-AM were coincident with those by TDEM. In both ESBLs and AmpCs-producing strains (n =11 ), 8 strains showed ESBI,s negative by DDET. In addition, beta lactamase and other broad-spectrum enzyme-producing strains identified by CTX-AM weren't detected by DDET method. Among 183 isolates, 33.9% produced only ESBLs, 3. 30% produced only AmpCs, 6.6% produced both ESBLs and AmpCs, and 14. 8% produced other β- lactamases. Imipenem showed the highest inhibitory activity against Enterobacteriaceae strains (MIC90= 0.5 mg/L). More than 72% of the isolates producing only ESBLs were susceptible to piperacillin/tazobactam, cefoxitin, cefoperazone/sulbactam and cefepime. More than 66% of the isolates producing only AmpCs were susceptible to cefepime. The antibiotic sensitivities of the isolates producing both ESBLs and AmpCs to tested β- lactam antibiotics other than imipenem were all below 20%. Conclusion The news method described above is easier to perform and interpret and cost-effective,allows for testing of ESBL and AmpCs on a single plate. Clinical laboratories can use this technique to detect the presence of ESBL and AmpCs. Imipenem is the first choice to cure the infection by ESBLs and/or AmpCs-producing Enterobacteriaceae.
出处 《国际检验医学杂志》 CAS 2007年第11期975-979,共5页 International Journal of Laboratory Medicine
关键词 肠杆菌 Β-内酰胺酶 超广谱Β-内酰胺酶 AMPCΒ-内酰胺酶 耐药性 Enterobacteriaceae beta lactamase Extended spectrum β lactamases AmpC β-lactamases Drug-resistant
  • 相关文献

参考文献10

  • 1National Committee for Clinical I.aboratory Standards. Performance standards for antimicrobial and susceptibility testing: 12th informational supplement (M-100-S12) [S]. National Committee for Clinical Laboratory Standards, Wayne, Pa. 2002.
  • 2Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center [J]. J Clin Microbiol, 2000, 38(5): 1791-1796.
  • 3Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat [J]. Clin Microbiol Rev, 2001, 14 (4): 933-951, table of contents.
  • 4Nasim K, Elsayed S, Pitout JD, et al. New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae [J]. J Clin Microbiol, 2004, 42 (10): 4799-4802.
  • 5原英,徐英春,陈民钧.介绍一种同时存在AmpC酶和超广谱β内酰胺酶的检测方法[J].中国抗感染化疗杂志,2003,3(1):28-30. 被引量:15
  • 6张乐海,傅云霜,马丽霞,许国生,伊长英,蒋芙蓉.双抑制剂扩散协同法检测两种超广谱β-内酰胺酶[J].中华检验医学杂志,2001,24(4):211-214. 被引量:36
  • 7刘丽文,卢艳平,张婵.产ESBLs及AmpC酶细菌检测方法的探讨[J].临床检验杂志,2003,21(6):335-336. 被引量:8
  • 8Pitout JD, Reisbig MD, Venter EC, et ah Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC beta-lactamases [J]. J Clin Microbiol, 2003, 41(8): 3933-3935.
  • 9Black JA, Thomson KS, Pitout JD. Use of beta-lactamase inhibilors in disk tests to detect plasmid-mediated AmpC beta-lactamases[J]. J Clin Microbiol, 2004, 42(5): 2203-2206.
  • 10Philippon A, Arlet G, Jacoby GA. Plasmid-determined AmpCtype beta-lactamases [J]. Antimicrob Agents Chemother, 2002, 46(1): 1-11.

二级参考文献12

  • 1National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing ninth information [S].Standard M100-S9. Pennsylvania: NCCLS, 1999.1-103.
  • 2Coudron P E, Moland E S, Thomson K S. Occurrence and detection of beta-lactamases among Escherichia coli, Klebsiella , and Proteus mirabilis isolmes at a veterans medical center [ J ]. J Clin Microbiol,2000,38(5) : 1791-1796.
  • 3Tzouvelekis L S, Vatopoulos A C, Katsanis G, et a]. Rare case of failure by an automated system to detect extended-spectrum heta-lactamases in a cephalosporin-resistant Klebsiella pnemoniae isolate [ J ]. J Clin Microbiol. 1999.37(7) :2388.
  • 4Pai H, Lyu S, Lee J H, et al. Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea[J]. J Clin Microbiol, 1999,37(6) : 1758- 1763.
  • 5Bush K,Jacoby G A, Medeiros A A. A function classification scheme for beurlactamases and its correlation with molecular structure [ J ]. Antimicrob Agents Chemother, 1995,39(3) : 1211-1233.
  • 6魏衍超,中华医学检验杂志,2000年,23卷,115页
  • 7Pai H,J Clin Microbiol,1999年,37卷,1758页
  • 8孙长贵,中华医学检验杂志,1999年,22卷,228页
  • 9孙长贵,陈汉美,颜秉兴,杨琳.评价三种筛选方法检测超广谱β-内酰胺酶及其临床应用[J].中华医学检验杂志,1999,22(4):228-231. 被引量:158
  • 10魏衍超,何志明,陈惠玲,张惠莲,李尚文,熊剑辉.革兰阴性杆菌对头孢吡肟广谱β-内酰胺类抗生素的耐药性[J].中华检验医学杂志,2000,23(2):115-116. 被引量:21

共引文献53

同被引文献24

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部